Rosacea

Medical Clinics of North America

Volumn 93, Issue 6, 2009, Pages 1183-1194

  Webster, Guy F ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Webster Dermatology   (United States)

Author keywords

Acne; Blush; Keratosis pilaris; Rhinophyma; Rosacea

Indexed keywords

AZELEIC ACID; BENZOYL PEROXIDE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DICARBOXYLIC ACID DERIVATIVE; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; METRONIDAZOLE; PENICILLIN G; RETINOIC ACID; STEROID; SULFACETAMIDE; TETRACYCLINE; UNCLASSIFIED DRUG;

ACNE; ADJUVANT THERAPY; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; BASAL CELL CARCINOMA; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DEMODEX; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG COST; DRUG DOSE REDUCTION; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; ENDOCRINE DISEASE; HISTOPATHOLOGY; HUMAN; KERATOSIS; LONG TERM CARE; LOW DRUG DOSE; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SKIN FLORA; SUSTAINED DRUG RELEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTI-BACTERIAL AGENTS; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; ISOTRETINOIN; RHINOPHYMA; ROSACEA;

EID: 70449627949     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2009.08.007     Document Type: Review

References (62)

1. Marks R. Rosacea, flushing and perioral dermatitis. In: Rook R, editor. Textbook of dermatology; p. 1851-63.
2. Savin J., Alexander S., and Marks R. A rosacea-like eruption of children. Br J Dermatol 82 (1972) 425-428
3. Berg M., and Liden S. An epidemiological study of rosacea. Acta Derm Venereol 69 (1989) 419-423
4. Wilkin J.K. Rosacea. [review]. Int J Dermatol 22 (1983) 393-400
5. Wilkin J.K. Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol 76 (1981) 15-18
6. Wilkin J.K. Rosacea. Pathophysiology and treatment. Arch Dermatol 130 (1994) 359-362
7. Fischer M., Gemende I., Marsch W.C., et al. Skin function and skin disorders in Parkinson's disease. J Neural Transm 108 (2001) 205-213
8. Dirschka T., Tronnier H., and Folster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol 150 (2004) 1136-1141
9. Laquieze S., Czernielewski J., and Baltas E. Beneficial use of cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea. J Dermatolog Treat 18 (2007) 158-162
10. Yamasaki K., DiNardo A., Bardan A., et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13 (2007) 975-980
11. Voegli R., Rawlings A.V., Doppler S., et al. Increased basal transepidermal water loss leads to elevation of some but not all stratum corneum serine proteases. Int J Cosmet Sci 30 (2008) 435-443
12. Rebora A., Drago F., and Picciotto A. Helilcobacter pylori in patients with rosacea. Am J Gastroenterol 89 (1994) 1603-1604
13. Diaz C., O'Calaghan C.J., Khan A., et al. Rosacea: a cutaneous marker for Helicobacter pylori infection?. Acta Derm Venereol 83 (2003) 282-286
14. Utas S., Ozbakir O., Turasan A., et al. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 40 (1999) 433-435
15. Sharma V.K., Lynn A., Kaminski M., et al. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal disease in patients with rosacea. Am J Gastroenterol 93 (1998) 220-222
16. Schneider M.A., Skinner R.B.J., and Rosenberg E.W. Serological determination of Helicobacter pylori in rosacea patients. [abstract]. Clin Res 40 (1992) 831
17. Bamford J.T.M., Tilden R.T., Blankush J.L., et al. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 135 (1999) 659-663
18. Wedi B., and Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol 3 (2002) 273-282
19. Leontiadis G.I., Sharma V.K., and Howden C.W. Non-gastrointestinal tract associations of Helicobacter pylori infection. What is the evidence?. Arch Intern Med 159 (1999) 925-940
20. Lacey N, Delaney S, Kavanagh K, et al. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 157:474-81.
21. Erbagci Z., and Ozgoztasi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol 37 (1998) 421-425
22. Roihu T., and Kariniemi A.L. Demodex mites in rosacea. J Cutan Pathol 25 (1998) 550-552
23. Wilkin J., Detmar M., Drake L., et al. Standard classification of rosacea. J Am Acad Dermatol 46 (2002)
24. Jansen T., and Plewig G. Rosacea: classification and treatment. J R Soc Med 90 (1997) 144-150
25. Forton F., and Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin surface biopsy. Br J Dermatol 128 (1993) 650-659
26. Bonnar E., Eustace P., and Powell F.C. The demodex mite population in rosacea. J Am Acad Dermatol 28 (1994) 443-448
27. Forton F., Germaux M.A., Rasseur B., et al. Demodicosis and rosacea: epidemiology and significance in daily dermatologic practice. J Am Acad Dermatol 52 (2005) 74-87
28. Powell F.C. Rosacea and the pilosebaceous follicle. Cutis 74 (2004) 32-34
29. Scerri L., and Saihan E.M. Persistent facial swelling in a patient with rosacea. Rosacea lymphedema. Arch Dermatol 131 (1995) 1071-1074
30. Bernardini F.P., Kersten R.C., Khouri L.M., et al. Chronic eyelid edema and ocular rosacea. Report of two cases. Ophthalmology 107 (2000) 2220-2223
31. Stone D.U., and Chodosh J. Ocular rosacea an update on pathogenesis and therapy. Curr Opin Ophthalmol 15 (2004) 499-502
32. Browning D.J., and Proia A.D. Ocular rosacea. Surv Ophthalmol 31 (1986) 145-158
33. Kligman A.M. Ocular rosacea: current concepts and therapy. Arch Dermatol 133 (1997) 89-90
34. Sobrin L., Liu Z., Monroy D.C., et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci 41 (2000) 1703-1709
35. Alfonso A.A., Sobrin L., Monroy D.C., et al. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 40 (1999) 2506-2512
36. Kerr REI, Thomsom J. Perioral dermatitis. In: Freedberg I, et al, editors. Dermatology in general medicine. 4th edition, p. 735-40.
37. Ramelet A.A., and Delacretaz J.J. Histopathological study of perioral dermatitis. Dermatologica 47 (1981) 163-171
38. Massa M.C., and Su W.P.D. Pyoderma faciale: a clinical study of twenty-nine patients. J Am Acad Dermatol 6 (1982) 84-91
39. Marks V.J., and Briggaman R.A. Pyoderma faciale, successful treatment with isotretinoin. J Am Acad Dermatol 17 (1987) 1062-1064
40. Leyden J.J., Thew M., and Kligman A.M. Steroid rosacea. Arch Dermatol 110 (1974) 619-622
41. Martin D.L., Turner M.L., and Williams C.M. Recent onset of smooth shiny erythematous papules on the face. Steroid rosacea secondary to topical fluorinated steroid use. Arch Dermatol 125 (1989) 828-831
42. Egan C.A., Rallis T.M., Meadows K.P., et al. Rosacea induced by beclomethasone dipropionate nasal spray. Int J Dermatol 38 (1999) 133-134
43. Goldman D. Tacrolimus ointment for the treatment of steroid induced rosacea, a preliminary report. J Am Acad Dermatol 44 (2001) 995-999
44. Wilkin J.K. Use of topical products for maintaining remission in rosacea. Arch Dermatol 135 (1999) 79-82
45. Weissbacher S., Merkl J., Hildebrandt B., et al. Pimecrolimus cream for papulopustular rosacea: a randomized vehicle controlled clinical trial. Br J Dermatol 156 (2007) 728-732
46. Marks R., and Harcourt-Webster J.N. Histopathology of rosacea. Arch Dermatol 100 (1969) 686-692
47. Dahl M.V., Katz H.I., Krueger G.G., et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol 134 (1998) 679-683
48. Neilson P.G. A double blind study of 1% metronidazole cream vs. systemic oxytetracycline therapy for rosacea. Br J Dermatol 109 (1983) 63-65
49. Madden S. A comparison of topical azeleic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 40 (1999) 961-965
50. Leyden J.J., Thiboutot D., and Shalita A. Photographic review of results from a clinical study comparing benzoyl peroxide 5% clindamycin 1% topical gel with vehicle in rosacea. Cutis 73 (2004) 11-17
51. Ertl G.A., Levine N., and Kligman A.M. A comparison of the efficacy of topical tretinoin and low dose oral isotretinoin in rosacea. Arch Dermatol 130 (1994) 319-324
52. Wereide K. Long term treatment of rosacea with oral tetracycline. Acta Derm Venereol 49 (1969) 176-179
53. Webster G.F. Treatment of rosacea. Semin Cutan Med Surg 20 (2001) 207-208
54. DelRosso J.Q. Systemic therapy for rosacea, focus on oral antibiotictherapy and safety. Cutis 66 (2000) 7-13
55. Van Vlem B., Vanholder R., De Paepe P., et al. Immunomodulating effects of antibiotics. Infection 24 (1996) 275-279
56. Ueyama Y., Misaki M., Ishihara Y., et al. Effects of antibiotics on polymorphonucleasr leukocyte chemotaxis in vitro. Br J Oral Maxillofac Surg 32 (1994) 96-99
57. Webster G.F., Toso S.M., and Hegemann L.R. Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Arch Dermatol 130 (1994) 748-752
58. Sanchez J., Somolinos A.L., Almodovar P.I., et al. A randomized double blind placebo controlled trial of the combine defect of doxyxycline hycalte 20 mg tablets and metronidazole 0.75% lotion in the treatment of rosacea. J Am Acad Dermatol 53 (2005) 791-797
59. DelRosso J.Q., Webster G.F., Jackson M., et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline administered once daily for treatment of rosacea. J Am Acad Dermatol 56 (2007) 791-802
60. Marsden J.R., Shuster S., and Neugebauer M. Response of rosacea to isotretinoin. Clin Exp Dermatol 9 (1984) 484-488
61. Laughlin S.A., and Dudley D.K. Laser therapy in the management of rosacea. J Cutan Med Surg 2 Suppl 4 (1998) S4-S24
62. West T.B., and Alster T.S. Comparison of the long pulse dye (590-595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Derm Surg 24 (1998) 510-512